In this episode of DeviceTalks Weekly, Managing Editor Kayleen Brown takes the helm, leading a keynote interview with Jenny Barba, co-founder of Features Capital. Barba shares her path into venture capital, identifies winning strategies for start-ups, and highlights some of the more exciting companies in the Features Capital portfolio.

A special thanks to this episode’s sponsor, SHL Healthcare, for supporting DeviceTalks! Go to www.shl-healthcare.com for more information. As a special bonus, download SHL Healthcare's complimentary white paper highlighting the outcomes of using the combination of advanced sewing, welding, and electromechanical assembly here: https://www.devicetalks.com/wp-content/uploads/2026/02/SHL-Healthcare_Whitepaper_Integrated-Approach.pdf

Kayleen Brown also leads our FOMO interview with Nick West, MD, chief medical officer of Shockwave Medical, part of Johnson & Johnson MedTech. They talk about the future calcium modification, intravascular lithotripsy, and the evolving treatment of vascular disease.

We’ll start things off with Host Tom Salemi and Chris Newmarker of MassDevice reviewing the newsmakers of the week - BioVentrix, Medical 21, VB Spine, Augmedics, Medtronic, Danaher, and Masimo.

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:06:47) - #5 BioVentrix & Medical 21 IPOs
(00:10:24) - #4 VB Spine acquires Augmedics
(00:11:35) - #3 Medtronic Stealth Access robotic system
(00:13:14) - #2 Medtronic earnings & growth updates
(00:17:00) - #1 Danaher to acquire Masimo
(00:23:15) - FOMO Interview – Nick West, MD, Chief Medical Officer, Shockwave Medical, part of Johnson & Johnson MedTech
(00:23:42) - Part 1 of our interview with Per Bjorkman, Chief Commercial Officer, SHL Healthcare
(00:41:31) - Keynote Interview, Jenny Barba, co-founder, Features Capital

How one venture firm is working to unlock MedTech; Where J&J/Shockwave is taking IVL next

DeviceTalks Podcast Network